Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Tauriga Sciences Inc. CBD (Cannabidiol) Infused TopiCanna Products Have Been Officially Launched

Accesswire December 16, 2014

Paris, France will Host BIO-Europe Spring® 2015 International Life Science Partnering Conference

Business Wire December 16, 2014

Ethernet Alliance Closes Out Eventful 2014, Looks Ahead to Exciting 2015

Business Wire December 16, 2014

Molecular Medicine Issues 20th Anniversary Edition

GlobeNewswire December 16, 2014

Unique Pizza and Subs Announces The Appointment of COO Bala Indurti

Accesswire December 16, 2014

PHENOGEN SCIENCES, INC. ANNOUNCES CLINICAL VALIDATION STUDY SUPPORTING THE USE OF BREVAGENPLUS(R) IN BREAST CANCER RISK ASSESSMENT

GlobeNewswire December 16, 2014

Looking for That Perfect Holiday Gift for the Person Who Has Everything?

PR Newswire December 16, 2014

Extreme Networks Appoints Bob Gault as Vice President of Global Channels and Partners

PR Newswire December 16, 2014

Plasma Fractionation Market Worth $25,383.4 Million by 2019

PR Newswire December 16, 2014

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

PR Newswire December 16, 2014

Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs

GlobeNewswire December 16, 2014

ETST, an Emerging Health and Wellness Company, Adds Attorney, Steven Warm, Esq., to the Advisory Board to Assist With Its New Cutting Edge Nutritional Products, Dietary Supplements and All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil Products

Marketwired December 16, 2014

BioMmune Technologies Inc. Announces the Appointment of Expert in Biologics as New Director

Marketwired December 16, 2014

Pitney Bowes Chooses Neo4j to Power Its Spectrum MDM Product Line

Marketwired December 16, 2014

PPD and ERT Establish Strategic Partnership to Enhance Drug Development

Business Wire December 16, 2014

HedgePath Pharmaceuticals Receives IND Clearance to Commence Development of its Proposed Cancer Treatment

PR Newswire December 16, 2014

Jinni Powers VUDU's New Discovery Experience with Robust Semantic Taste & Mood Based Features

Business Wire December 16, 2014

Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance

Business Wire December 16, 2014

Fruit Flies And Flowers And Brain - Oh My!

PR Newswire December 16, 2014

NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity in Glioblastoma Xenograft Models

PR Newswire December 16, 2014